Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: K99CA286709
NCI NIH HHS
Grant: K08CA245188
NCI NIH HHS
Grant: R37CA280692
NCI NIH HHS
Grant: R01CA264133
NCI NIH HHS
Grant: K08CA256179
NCI NIH HHS
Grant: P30 CA069533
National Institutes of Health
Grant: 3P30CA069533-21S3
OHSU Knight Cancer Institute
National Institutes of Health
Grant: 5R37CA280692-03
Metabolic vulnerability due to dysregulated lipid metabolism in PDAC cachexia
National Institutes of Health
Grant: 1R01CA264133-01
PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia
National Institutes of Health
Grant: 5K08CA256179-02
Targeting an unrecognized checkpoint on T cell function in tumors
National Institutes of Health
Grant: 5K08CA245188-05
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
Fields of Study
Keywords